Received Apr 27, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 59px7 | IM / LA |
Site: Bruising at Injection Site-Mild, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Systemic: Exhaustion / Lethargy-Medium, Systemic: Headache-Medium, Additional Details: Patient develped shingles after vaccine, she went to the doctors, they advised her to come so we could document.